Early Pregnancy Failure: Factors Affecting Successful Medical Termination

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The main purpose of our study was to which determine factors, those measured by ultrasound and also demographic and clinical factors (age, number of previous pregnancies, abortions and deliveries) predict outcome of medical treatment for early pregnancy failure. Our hypothesis was that gestational sac volume predicts outcome of medical treatment for early pregnancy failure.

See also
Status	Clinical Trial	Phase
Terminated	`NCT03212352` - Comparing Two Medical Treatments for Early Pregnancy Failure.	Phase 4
Completed	`NCT03178682` - Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss	N/A
Terminated	`NCT00468299` - MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure	N/A

NCT number	NCT00782860
Study type	Observational
Source	Western Galilee Hospital-Nahariya
Contact
Status	Completed
Phase	N/A

Early Pregnancy Failure: Factors Affecting Successful Medical Termination Treatment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms